Somewhat Favorable News Coverage Very Likely to Impact CME Group (NASDAQ:CME) Share Price
Media stories about CME Group (NASDAQ:CME) have trended somewhat positive on Thursday, Accern reports. The research group identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. CME Group earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 84 out of 100, indicating that recent news coverage is very likely to have an effect on the company’s share price in the near term.
These are some of the news articles that may have impacted Accern Sentiment’s analysis:
- Ronald A. Pankau Sells 300 Shares of CME Group Inc. (CME) Stock (americanbankingnews.com)
- CME Group Inc. (CME) Chairman Terrence A. Duffy Sells 21,815 Shares (americanbankingnews.com)
- CME Group Inc. (CME) Declares Quarterly Dividend of $0.66 (americanbankingnews.com)
- Thanks to ETFs, S&P 500 Companies Have a New Boss — the S&P 500 (bloomberg.com)
- Shionogi Inc. President and CEO John Keller to Receive Innovation Award from NY American Chemical Society CME Group (bizjournals.com)
CME Group (NASDAQ CME) traded up 0.67% during mid-day trading on Thursday, reaching $124.99. 1,360,538 shares of the company were exchanged. The stock has a 50 day moving average of $123.71 and a 200-day moving average of $120.57. CME Group has a one year low of $98.95 and a one year high of $127.96. The stock has a market capitalization of $42.47 billion, a price-to-earnings ratio of 32.89 and a beta of 0.73.
CME Group (NASDAQ:CME) last released its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.62%. The company had revenue of $925 million for the quarter, compared to analysts’ expectations of $931.05 million. During the same quarter last year, the business earned $1.14 EPS. The firm’s revenue was up 2.1% compared to the same quarter last year. On average, equities analysts expect that CME Group will post $4.82 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is 53.99%.
CME has been the topic of several analyst reports. Deutsche Bank AG reduced their price target on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a research report on Thursday, April 6th. Royal Bank Of Canada reduced their price target on shares of CME Group from $134.00 to $133.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 19th. UBS AG reaffirmed a “buy” rating and set a $134.00 price target (down previously from $136.00) on shares of CME Group in a research note on Monday, June 5th. BidaskClub raised shares of CME Group from a “sell” rating to a “hold” rating in a research note on Friday, June 23rd. Finally, Jefferies Group LLC restated a “buy” rating and issued a $128.00 price target on shares of CME Group in a report on Monday, July 10th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $131.63.
In other news, insider Kathleen M. Cronin sold 8,125 shares of CME Group stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total transaction of $1,034,718.75. Following the sale, the insider now owns 38,174 shares in the company, valued at $4,861,458.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Chairman Terrence A. Duffy sold 21,815 shares of CME Group stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the sale, the chairman now owns 110,711 shares in the company, valued at approximately $13,715,985.79. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 69,770 shares of company stock worth $8,569,114. 0.61% of the stock is owned by company insiders.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.